INPATIENT PROGRESS NOTE

HOSPITAL DAY : 4

IDENTIFICATION / CHIEF CONCERN :
Mr. Bounkeua is a 51 year old man w / h/o DLBCL s/p R-CHOP C4 on 2010 , who is now on D4 of EPOCH for relapsed lymphoproliferative disorder ( DLBCL vc T cell )

INTERVAL HISTORY :
- He did tolerate well chemo w / o nausea .
- Constipation resolved
- No TLS
- VSS and no fevers

SCHEDULED MEDICATIONS :
cyclophosphamide 1 , 390 mg IVPB Once
enoxaparin 40 mg Subcutaneous QHS
insulin LISPRO BEDTIME LOW Correction Subcutaneous QHS
insulin LISPRO LOW Correction - Premeal Subcutaneous TID Before Meals
MiraLax 17 g PO BID
ondansetron 8 mg IV Q12 Hours ( non std )
predniSONE 110 mg PO BID
raNITIdine 150 mg PO BID
senna 17.2 mg PO Daily
sodium chloride 0.9 % - Flush 10 mL IV Daily

INFUSIONS :
Sodium Chloride 0.9 % 1 , 000 mL 50 mL/hr IV Infusion

PRN MEDICATIONS : ( only those given in the last 24 hours are displayed )
bisacodyl 10 mg Rectal Daily PRN
LORazepam 0.5-1 mg PO Q4 Hours PRN
LORazepam 0 . 5mg to 1 mg PO QHS PRN

REASON DEVICES REMAIN IN :
PICC ( Day 4 ) , R arm , Double Lumen , Power Injectable , Other : 41/3/27 / 3CG , At bedside : In place for chemotherapy

PHYSICAL EXAM :
10/20/16 07:34 : T 36.6 HR 62 RR 16 BP 117 / 75 O2 Sat 94 % on RA
In : 1950.98 ; Out : 3725 ; Net : -1774.02 ( last 24 hours )
GENERAL : Appears stated age , in no acute distress
NECK : supple
HEENT : NCAT , anicteric sclera , EOM grossly intact
CV : RR , no LE edema
RESP : breathing comfortably on RA
ABD / GI : non distended
SKIN : No new obvious rashes or lesions
NEURO : Alert & oriented .
PSYCH : euthymic mood , affect congruent . Speech normal rate and volume .

LABS : ( Most recent results in 24 hour range . )

RESULTS FROM TODAY
RESULTS FROM YESTERDAY

10/20/16 00:05
10/19/16 00:45


| - ICa - - -
| - ICa - - -
134
105
18
| - Ca 8.5

137
105
16
| - Ca 8.9
- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 180
| - Mg 1.8

- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 162
| - Mg 1.9
3.9
24
0.87
| - Phos 2.4

3.9
27
0.81
| - Phos - - -


RESULTS FROM TODAY
RESULTS FROM YESTERDAY

10/20/16 00:05
10/19/16 00:45


11.1
| - PT - - -
11.2
| - PT - - -
4.53 ] - - - - - - - - - - - - - - - - - - - - - - [ 163
| - INR - - -
5.50 ] - - - - - - - - - - - - - - - - - - - - - - [ 180
| - INR - - -

34
| - PTT - - -
33
| - PTT - - -


ASSESSMENT AND PLAN
Mr. Bounkeua is a 51 year old man w / h/o DLBCL s/p R-CHOP C4 on 2010 , who is now on D4 of EPOCH for relapsed lymphoproliferative disorder ( DLBCL vc T cell )

Lymphoproliferative disorder ( DLBCL vs T cell ) on D4 EPOCH
- Clinically splenomegaly shrunk , which is reassuring .
- Will receive today Day 5 of EPOCH : CTX + Dexa

Chemo toxicity :
- Nausea well controlled on Zofran 8 mg Q12hr and Ativan 1 mg for breakthrough nausea
- Constipation likely from Vincristine , resolved on Bisacodyl 10 mg PR and Senna 8 . 6mg PO

Chronic / Stable / Resolved :
Diabetes : Mild diabetes secondary to long term prednisone use , was on metformin intermittently while outpatient .
- LDSSI

Anxiety : As an outpatient , Mr. Bounkeua takes both Ativan and Ambien for sleep / anxiety . Most recently , he reports taking 1 - 4mg PO and his most recent use was the night prior to admission .
- Continuing 0.5-1 mg PO Ativan prn for anxiety

Hx of DVT : Reports previously being on Xarelto , but has not been taking this for the past 6 months .
- profilactic Enoxaparin
- restarting Xarelto upon discharge , pt will need to hold the day before if gets port as outpt

VTE prophylaxis :
Risk Level : At Risk
Treatment ( s ) ordered : Enoxaparin 40mg / 0 . 4mL inj . 40 mg , 0.4 mL , Subcutaneous , QHS - - > will transition to xarelto upon DC .
Contacts : partner at bedside
Code status : Full
Discharge plan : Home likely friday .

ATTENDING STATEMENT :
I saw and evaluated the patient and agree with Dr. Bezerra 's note .

Date of Service : 10/20/2016

Today 's Date is : 10/20/2016